Matches in SemOpenAlex for { <https://semopenalex.org/work/W148889373> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W148889373 endingPage "613" @default.
- W148889373 startingPage "610" @default.
- W148889373 abstract "Objectives: To determine the variation in the methods used to assess and interpret the reversibility of airflow limitation in lung-function laboratories throughout Australia and New Zealand. Design: A postal survey performed in 2000, requesting details of methods used to assess and interpret bronchodilator reversibility. Setting and participants: 60 lung-function laboratories identified from the Australian and New Zealand Society of Respiratory Science mailing list. Main outcome measures: Bronchodilator agent, dose, mode of administration, time to repeat spirometry and definition of a significant response. Results: 37 laboratories responded (response rate, 64%). Thirty-three laboratories used salbutamol as their routine bronchodilator agent. Twenty-four laboratories used a metered-dose inhaler (MDI) with (21) or without (3) a spacer device as the preferred mode of bronchodilator administration. There was wide variation in the bronchodilator dose administered (median, 400 μg; range, 200–800 μg salbutamol for MDIs) and the time to repeat spirometry following bronchodilator administration (median, 10 min; range, 4–20 min). Ten laboratories used criteria consistent with either the National Asthma Council or Thoracic Society of Australia and New Zealand COPDX guidelines to define a significant bronchodilator response, and two used American Thoracic Society criteria. The remaining 25 respondents listed a variety of other criteria. Conclusion: The methods used to assess and interpret acute bronchodilator reversibility in lung-function laboratories in Australia and New Zealand vary considerably. This may have a significant effect on the diagnosis and management of patients. Laboratories should report the method used to assess bronchodilator response." @default.
- W148889373 created "2016-06-24" @default.
- W148889373 creator A5036210085 @default.
- W148889373 creator A5036932736 @default.
- W148889373 creator A5054447629 @default.
- W148889373 creator A5090747493 @default.
- W148889373 date "2004-06-01" @default.
- W148889373 modified "2023-10-16" @default.
- W148889373 title "Bronchodilator reversibility testing: laboratory practices in Australia and New Zealand" @default.
- W148889373 cites W1964669374 @default.
- W148889373 cites W1983444168 @default.
- W148889373 cites W2018683408 @default.
- W148889373 cites W2058411887 @default.
- W148889373 cites W2104356664 @default.
- W148889373 cites W2170657953 @default.
- W148889373 cites W2470017835 @default.
- W148889373 cites W2509618390 @default.
- W148889373 cites W4249200669 @default.
- W148889373 doi "https://doi.org/10.5694/j.1326-5377.2004.tb06121.x" @default.
- W148889373 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15200356" @default.
- W148889373 hasPublicationYear "2004" @default.
- W148889373 type Work @default.
- W148889373 sameAs 148889373 @default.
- W148889373 citedByCount "19" @default.
- W148889373 countsByYear W1488893732017 @default.
- W148889373 countsByYear W1488893732019 @default.
- W148889373 countsByYear W1488893732020 @default.
- W148889373 countsByYear W1488893732022 @default.
- W148889373 countsByYear W1488893732023 @default.
- W148889373 crossrefType "journal-article" @default.
- W148889373 hasAuthorship W148889373A5036210085 @default.
- W148889373 hasAuthorship W148889373A5036932736 @default.
- W148889373 hasAuthorship W148889373A5054447629 @default.
- W148889373 hasAuthorship W148889373A5090747493 @default.
- W148889373 hasConcept C126322002 @default.
- W148889373 hasConcept C1862650 @default.
- W148889373 hasConcept C2776042228 @default.
- W148889373 hasConcept C2777394947 @default.
- W148889373 hasConcept C2777714996 @default.
- W148889373 hasConcept C2780261241 @default.
- W148889373 hasConcept C2780333948 @default.
- W148889373 hasConcept C2780667556 @default.
- W148889373 hasConcept C2781018748 @default.
- W148889373 hasConcept C2909548125 @default.
- W148889373 hasConcept C3018587741 @default.
- W148889373 hasConcept C42219234 @default.
- W148889373 hasConcept C71924100 @default.
- W148889373 hasConcept C75603125 @default.
- W148889373 hasConceptScore W148889373C126322002 @default.
- W148889373 hasConceptScore W148889373C1862650 @default.
- W148889373 hasConceptScore W148889373C2776042228 @default.
- W148889373 hasConceptScore W148889373C2777394947 @default.
- W148889373 hasConceptScore W148889373C2777714996 @default.
- W148889373 hasConceptScore W148889373C2780261241 @default.
- W148889373 hasConceptScore W148889373C2780333948 @default.
- W148889373 hasConceptScore W148889373C2780667556 @default.
- W148889373 hasConceptScore W148889373C2781018748 @default.
- W148889373 hasConceptScore W148889373C2909548125 @default.
- W148889373 hasConceptScore W148889373C3018587741 @default.
- W148889373 hasConceptScore W148889373C42219234 @default.
- W148889373 hasConceptScore W148889373C71924100 @default.
- W148889373 hasConceptScore W148889373C75603125 @default.
- W148889373 hasIssue "12" @default.
- W148889373 hasLocation W1488893731 @default.
- W148889373 hasOpenAccess W148889373 @default.
- W148889373 hasPrimaryLocation W1488893731 @default.
- W148889373 hasRelatedWork W148889373 @default.
- W148889373 hasRelatedWork W1967616871 @default.
- W148889373 hasRelatedWork W1967821954 @default.
- W148889373 hasRelatedWork W2008150084 @default.
- W148889373 hasRelatedWork W2160654785 @default.
- W148889373 hasRelatedWork W2252156554 @default.
- W148889373 hasRelatedWork W2399767733 @default.
- W148889373 hasRelatedWork W2421557730 @default.
- W148889373 hasRelatedWork W3013665003 @default.
- W148889373 hasRelatedWork W3194434682 @default.
- W148889373 hasVolume "180" @default.
- W148889373 isParatext "false" @default.
- W148889373 isRetracted "false" @default.
- W148889373 magId "148889373" @default.
- W148889373 workType "article" @default.